In this breakout session from our March 2021 virtual event, ‘Human Biology: An Exploration of Organs-on-Chips,’ we give an overview of our Colon Intestine-Chip and how it can be applied to study cytokine-mediated inflammation, anti-inflammatory thereapeutic efficacy, and (coming soon) immune cell recruitment.
Watch the Full Virtual Event
Click here to watch the full event, and learn how Organs-on-Chips technology is transforming therapeutic research. The event features informative breakout sessions on neurology, inflammation, infectious diseases, and the future of Organs-on-Chips.
Emulate Inc. is a privately held company that creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health. Our lab-ready Human Emulation System® includes three components: Zoë® Culture Module, Organ-Chips, and analytical software applications. The platform provides a window into the inner workings of human biology and disease—offering researchers a new technology designed to predict human response with greater precision and detail than conventional cell culture or animal-based experimental testing. Each of the Emulate proprietary Organ-Chip models—including the liver, intestine, and kidney—contains tiny hollow channels lined with tens of thousands of living human cells and tissues and is approximately the size of an AA battery. An Organ-Chip is a living, microengineered environment that recreates the natural physiology and mechanical forces that cells experience within the human body. Our founding team pioneered the Organs-on-Chips technology at the Wyss Institute for Biologically Inspired Engineering at Harvard University. Emulate holds the worldwide exclusive license from Harvard University to a robust and broad intellectual property portfolio for the Organs-on-Chips technology and related systems. For more information, please visit emulatebio.com.